金融
49 分钟前
Dexcom 的赌注超越糖尿病
Dexcom 首席执行官杰克·利奇 (Jake Leach) 加入彭博未平仓合约，解释为什么连续血糖监测仪变得比糖尿病设备大得多。他说 GLP-1 药物实际上促进了 CGM 的采用，并捍卫了公司的地位
原文
Dexcom’s Bet Beyond Diabetes
Dexcom CEO Jake Leach joined Bloomberg Open Interest to explain why continuous glucose monitors are becoming much bigger than diabetes devices. He says GLP-1 drugs are actually boosting CGM adoption and defends the compa